| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 贵州赤天化股份有限公司是以煤化工+医药大健康双主业发展的大型企业集团，既是贵州省最大的氮肥、甲醇生产企业，又是贵州省重点扶持的医药大健康产业集团。股票代码：600227。 旗下斥资57亿元兴建的贵州赤天化桐梓化工有限公司是一家集生产、开发、销售为一体的煤化工高新技术企业。具有合成氨30万吨、甲醇30万吨，尿素52万吨，10万吨复合肥的强大产能。 贵州圣济堂制药有限公司是国内知名的糖尿病药品专业生产企业，现拥有十余条GMP生产线，其中独家生产的民族药“九龙解毒胶囊”、“胆清胶囊”“重楼解毒酊”、“复方重楼酊”“博性康药膜”荣获国家级发明专利。 贵州大秦肿瘤医院是按国家三甲肿瘤专科医院标准设计建造的医疗健康项目，将建成西南地区专科性最强，集医疗、教学、科研、预防、舒缓、康养、生物医药、健康产业“八位一体”的国际化研究型高水平肿瘤医院。 贵州中观生物技术有限公司是2016年与美国专家团队合作成立，致力于干细胞治疗和免疫细胞治疗的研发和应用。目前已建立具有国际水平，国内领先，集干细胞、免疫细胞制备、人体器官3D打印及细胞新药研发为一体的研发平台。中观生物申报干细胞治疗糖尿病、膝骨关节炎等项目分别获得国家卫健委和国家药监局的备案和审批，已经进入临床研究，同时公司现储备有干细胞治疗卵巢早衰、股骨头坏死、脑卒中、NK细胞、类分湿关节炎、抑郁症/老年痴呆等新药研发项目。 赤天化股份秉承“圣心为怀，济世为本”，凭借雄厚的经济实力、专业的优秀人才、前沿的技术支撑、强大的研发力量，为工业强省做出贡献。 | ||||||||||||||||||||||||
| Main Business | 从事化工业务、医疗服务业务和煤炭业务。 | ||||||||||||||||||||||||
| Legal Representative | 丁林洪 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 先正红 | ||||||||||||||||||||||||
| Solicitors | 北京国枫律师事务所 | ||||||||||||||||||||||||
| Auditors | 亚太（集团）会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0851-84397219;0851-84396315 | ||||||||||||||||||||||||
| Fax No | 0851-84391503 | ||||||||||||||||||||||||
| Website | www.gzcth.net | ||||||||||||||||||||||||
| SJT_zqb@163.com;177848551@qq.com;357720435@qq.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 21/02/2000 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.070 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 1.578 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.015B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |